Skip to content
Recall Observatory FDA recall evidence

Drug product

Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)

D-0020-2023

September 30, 2022

Class II

Product summary

Firm
AuroMedics Pharma LLC
Event
Event 90925
Status
Terminated
Classification
Class II
Quantity
11,520 units
Official record key
drug-enforcement:D-0020-2023

Official wording

Reason: Subpotent Drug: Out of specification for assay

Code information: Lot # CFN200020, EXP Nov. 2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent